Ferrere assists in Biogen’s expansion
Friday, 27th January 2012 by Rosie Scammell
Ferrere Abogados has helped biotechnology company Biogen Idec gain an operating licence for multiple sclerosis drug Avonex.
Latin Lawyer is the definitive information resource for business law in Latin America. Individual and Firmwide subscriptions are available to access subscriber content including news, features, and the Latin Lawyer 250. For more information see Subscriptions.
This content can only be accessed by Latin Lawyer subscribers
Subscribe to access the latest news, analyses, features, interviews and over 14,000 stories published since 2000.
If you are a Latin Lawyer subscriber, please login to access this content:
